044-235-16-29, 050-336-86-07

з 8:00 до 16:30 (Сб, Нд вихідні)

Phthisiology: textbook / V.I. Petrenko, O.K. Asmolov, M.G. Boyko et al.; edited by V.I. Petrenko. — 2nd edition

Phthisiology: textbook / V.I. Petrenko, O.K. Asmolov, M.G. Boyko et al.; edited by V.I. Petrenko. — 2nd edition

В наявності
560 грн392 грн
Автори: В.І. Петренко, О.К. Асмолов, М.Г. Бойко та ін.; за ред. В.І. Петренка
Гриф: затверджено МОЗ України
Аудиторія: для студентів вищих медичних навчальних закладів
Видавництво: Всеукраїнське спеціалізоване видавництво «Медицина»
Мова: англійська
Рік і номер видання: 2018, 2-е (стереотипне)
Кількість сторінок: 416 (кольорові)
ISBN: 978-617-505-687-5
Всеукраїнське спеціалізоване
видавництво «Медицина»

Опис книги Phthisiology: textbook / V.I. Petrenko, O.K. Asmolov, M.G. Boyko et al.; edited by V.I. Petrenko. — 2nd edition

Professional training of medical professionals of the general practicioners network is a very important task, since they are an important element in addressing the TB epidemic. Therefore there was a need for a national textbook of tuberculosis involving Ukrainian and foreign highly skilled professionals in this field, who have invaluable clinical, teaching and research experience. Textbook meets the requirements of the Bologna process. It provides information about the etiology, pathogenesis, clinical presentation, diagnosis, treatment and prevention of tuberculosis. Texbook expounds latest achievements of national and international scientists, WHO standardized protocols in compliance with consistency and volume of standard provision of specialized care for TB patients. 
For students in higher education institutions.

Зміст книги Phthisiology: textbook / V.I. Petrenko, O.K. Asmolov, M.G. Boyko et al.; edited by V.I. Petrenko. — 2nd edition

Key terms & abbreviations
Chapter 1. General basics of phthisiology
1.1. History of Phthisiology (V.I. Petrenko)
1.2. Basics of TB Control and Elimination (Pierpaolo di Colombani)
1.3. The Stop TB Strategy (Pierpaolo di Colombani)
1.3.1. TB Control and Styblo’s Model
1.3.2. The DOTS Strategy
1.3.3. The Stop TB Strategy
1.4. Epidemiology and Control of TB at the Global Level (Richard Zaleskis)
1.4.1. Basics of TB Epidemiology
1.4.2. TB Epidemiology in the World and in the European Region
1.4.3. Combating TB in the World and in the European Region
1.4.4. Achievements in TB Control
1.4.5. Main Challenges in TB Control
1.4.6. Next Steps in Global TB Control and its Eradication
1.5. TB Epidemiology and Control in Ukraine (O.S. Shevchenko)
1.5.1. TB Control in Ukraine
1.5.2. General Issues on TB Epidemiology
1.5.3. Epidemiology of TB in Ukraine
1.6. Prevention of TB (Giovanni Battista Migliori)
1.6.1. Social Determinants and Noncommunicable Diseases (Giovanni Battista Migliori)
1.6.2. Contact Tracing (Giovanni Battista Migliori)
1.6.3. BCG Vaccination (Giovanni Battista Migliori, Richard Zaleskis)
1.6.4. Psychological Aspects of Stigma and Discrimination of Patients with Tuberculosis and TB/HIV Co­infection (L.D. Todoriko)
1.7. Infection Control (S.M. Ljepshina)
1.7.1. Infection Control Rationale (Definition)
1.7.2. TB Infection Control in Healthcare Facilities
1.7.3. Administrative Control
1.7.4. Environmental Control/Control of Air Indoors
1.7.5. Personal Respiratory Protection
1.7.6. Infection Control in TB Patients’ Homes
Chapter 2. Etiology and pathogenesis of tuberculosis
2.1. TB Etiology (V.I. Petrenko, O.S. Shevchenko)
2.1.1. Causative Agent of TB and Its Types
2.1.2. MTB Replication
2.1.3. MTB Structure
2.1.4. MTB Genetics
2.1.5. MTB Resistance to Anti­TB Drugs
2.1.6. Environmental Stability of MTB
2.1.7. Non­Tuberculosis (Atypical) Mycobacteria
2.2. Pathogenesis of Tuberculosis (O.K. Asmolov, V.I. Petrenko)
2.2.1. Immunophysiology and Immunopathology of Tuberculosis
2.2.2. Pathophisiology of Tuberculosis
Chapter 3. Detection and diagnosis of tuberculosis
3.1. Case Finding, Diagnosis and Screening (Giovanni Battista Migliori)
3.1.1. Case­finding
3.1.2. Diagnosis
3.1.3. Screening
3.1.4. From Diagnosis to Registration
3.2. Practical Approach to Lung Health (PAL) (Giovanni Battista Migliori)
3.3. Methodology of TB Patient Observation
3.3.1. Case History (V.I. Petrenko)
3.3.2. Physical Examination (V.I. Petrenko)
3.3.3. Haematology (V.I. Petrenko)
3.3.4. Biochemistry (V.I. Petrenko)
3.3.5. Laboratory Testing for MTB (V.I. Petrenko, Richard Zaleskis)
3.3.6. The Role of Tuberculin Skin Test (Mantoux Test) in Diagnosis of TB (Giovanni Battista Migliori, V.I. Petrenko)
3.3.7. Other Immunology Testing for Tuberculosis in Ukraine (V.I. Petrenko)
3.3.8. Radiological Diagnosis (V.I. Petrenko)
3.3.9. Functional Tests (L.A. Gryschuk)
3.3.10. Instrumental Diagnostics (V.I. Petrenko)
Chapter 4. Treatment of patients with tuberculosis
4.1. Brief Historical Overview of the Development of Antimycobacterial Therapy (Vaira Laimane)
4.2. Principles of Treatment of Patients with Tuberculosis (V.I. Petrenko)
4.3. Antimycobacterials. Theoretical Basis of Antituberculosis Treatment (V.I. Petrenko, Vaira Laimane)
4.3.1. Antituberculosis Drugs Activity
4.3.2. Bacteriologic Bases for TB Treatment (Vaira Laimane)
4.3.3. Antituberculosis Drugs (V.I. Petrenko, Richard Zaleskis)
4.3.4. Side Effects of Anti­TB Drugs (B.M. Puchlykh)
4.4. Treatment of Susceptible TB (Vaira Laimane)
4.4.1. The Aims of Susceptible TB Treatment
4.4.2. Standardized Treatment Regimens for Active Tuberculosis in Defined Patient Groups (L.D. Todorico)
4.4.3. Phases of Treatment of Pulmonary and Extra Pulmonary Tuberculosis
4.4.4. Evidence Based Recommendations for Tuberculosis Treatment
4.4.5. Recommended Treatment Regimens for New Pulmonary TB Cases
4.4.6. Recommended Treatment for Previously Treated TB Cases (Relapses, Treatment after Failure, and Treatment after Default)
4.4.7. Monitoring of TB Treatment Response
4.5. Adjuvant Therapy in Ukraine
4.6. Surgical Treatment of Patients with Tuberculosis (I.D. Duzhij)
4.6.1. Historical Overview on Surgery for Tuberculosis
4.6.2. Current Indications for Surgery in TB
4.6.3. Contraindications for Surgery in TB
4.6.4. Types of Surgical Operations
4.6.5. Pre­ and Post­Surgical Follow­up
4.7. Patients’ Support and DOT (Vaira Laimane)
4.7.1. Importance of Adherence to TB Treatment
4.7.2. Patient­Centered Approach
4.7.3. Directly Observed Therapy (DOT)
4.7.4. Treatment for TB in Hospital
4.7.5. Delivering DOT on Ambulatory Bases
4.7.6. TB Patient Education
Chapter 5. Clinical forms of tuberculosis (V.I. Petrenko, M.G. Boyko)
5.1. Classification of Tuberulosis
5.1.1. International Classification of Tuberculosis
5.1.2. Classification of TB in Ukraine
5.1.3. Formulation of TB Diagnosis
5.2. The Primary Tuberculosis
5.2.1. Overview of Primary TB Forms
5.2.2. Tuberculosis of the Nondefined Localization/Primary Site
5.2.3. Primary TB Complex
5.2.4. TB of Intrathoracic Lymph Nodes Tuberculosis
5.2.5. Complications of the Primary Tuberculosis
5.2.6. Specific Features of the Primary Tuberculosis in Different Age Groups
5.3. The Secondary Tuberculosis
5.3.1. Disseminated Pulmonary Tuberculosis
5.3.2. Focal Pulmonary Tuberculosis
5.3.3. Infiltrative Pulmonary Tuberculosis
5.3.4. Caseous Pneumonia
5.3.5. Pulmonary Tuberculoma
5.3.6. Fibrotic­Cavitary Pulmonary Tuberculosis
5.3.7. Cirrhotic Pulmonary Tuberculosis
5.3.8. Pulmonary Tuberculosis Associated with Occupational Dust­related Pulmonary Disease (Coniotuberculosis)
5.4. Complications of Pulmonary Tuberculosis
5.4.1. Respiratory Insufficiency/Failure
5.4.2. Cor Pulmonale
5.4.3. Haemoptysis and Pulmonary Bleeding
5.4.4. Spontaneous Pneumothorax
5.4.5. Atelectasis
5.4.6. Amyloidosis of Internal Organs
5.4.7. Bronchial and Thoracic Fistulae
5.5. Residual Changes after Pulmonary Tuberculosis
5.6. Tuberculosis of Respiratory Organs Associated with Other Illnesses and Conditions
5.6.1. Pulmonary Tuberculosis and Non­Specific Respiratory Disease
5.6.2. Pulmonary Tuberculosis and Diabetes Mellitus
5.6.3. Pulmonary Tuberculosis and Gastric and Duodenal Ulcer
5.6.4. Pulmonary Tuberculosis and Alcoholism
5.6.5. Pulmonary Tuberculosis and Cancer
5.6.6. Tuberculosis in Pregnancy and Lactation
5.6.7. Tuberculosis in Children
5.6.8. Tuberculosis in the Elderly and Aged People
5.7. Extrapulmonary tuberculosis
5.7.1. Tuberculosis of bronchi, trachea, larynx and upper respiratory tract
5.7.2. Tuberculosis pleurisy (including empyema)
5.7.3. Neuro­tuberculosis and meningeal tuberculosis
5.7.4. Boneandjoint tuberculosis
5.7.5. Genitourinary tuberculosis
5.7.6. Tuberculosis of peripheral lymph nodes
5.7.7. Abdominal tuberculosis
5.7.8. Miliary tuberculosis
5.7.9. Skin, subcutaneous tissue and ocular tuberculosis
Chapter 6. Drug resistant tuberculosis and tb/hiv oinfection
6.1. Epidemiology of Multidrug Resistant Tuberculosis (Giovanni Battista Migliori)
6.1.1. Risk Factors for MDR­TB and XDR­TB Development
6.2. Diagnostics and Treatment of Drug­Resistant TB (Giovanni Battista Migliori)
6.2.1. Clinical Features of MDR­TB and XDR­TB
6.2.2. Establishing Diagnosis of Drug­resistant TB
6.2.3. New Technologies for Rapid Diagnosis of MDR­TB
6.2.4. Conservative Drug Treatment of Drug­resistant TB
6.2.5. Failure of Therapy and Retreatment Regimens
6.2.6. Treatment Monitoring  for Drug­resistant TB
6.2.7. Risk Factors and Treatment Outcomes of MDR­TB Treatment
6.2.8. Surgical Treatment for MDR­TB and XDR­TB
6.3. Control of MDR­TB and XDR­TB (Giovanni Battista Migliori)
6.3.1. Infection Control Measures and Recommendations
6.3.2. Global Recommendations for Prevention and Control of Drug­resistant TB
6.4. TB/HIV Co­infection (Alberto Mattelli)
6.4.1. Epidemiology
6.4.2. Diagnosis and Treatment of TB/HIV
6.4.3. Diagnostics of Tuberculosis among HIV Infected Persons
6.4.4. Treatment of TB and HIV Co­infection
6.4.5. Prevention of TB in HIV­infected People
6.4.6. Control of TB/HIV Co­infection
Chapter 7. Treatment of latent tuberculosis infection (Richard Zaleskis, V.I. Petrenko)
7.1. Introduction
7.2. Recommended Regimens for Treatment of Latent TB Infection and Their Effectiveness
Chapter 8. New perspectives in development of phthysiology (Giovanni Battista Migliori)
8.1. New Technologies in TB Diagnostics
8.1.1. The New Diagnostics
8.1.2. Improving Culture and Drug Susceptibility Testing
8.1.3. Looking for Biomarkers: Mycobacterial Lipoarabinomannan (LAM)
8.1.4. Immunodiagnostic Methods: Are They Able to Differentiate TB Infection and Disease?
8.1.5. Other New Diagnostic Techniques 
8.1.6. World Health Organization Policy Statement on Commercial Serodiagnostic Tests
8.2. New Medications
8.2.1. Priority Areas for Research in Anti­TB Drugs
8.2.2. Methodological Issues in Anti­TB Drug Development
8.2.3. Anti­TB Drugs Presently Undergoing Clinical Trials
8.3. Vaccines
8.3.1. BCG Vaccine
8.3.2. The Two Vaccination Strategies: Pre­exposure and Post­exposure
8.3.3. The Roadmap for the Future

Автори книги Phthisiology: textbook / V.I. Petrenko, O.K. Asmolov, M.G. Boyko et al.; edited by V.I. Petrenko. — 2nd edition

V.I. Petrenko, O.K. Asmolov, M.G. Boyko, M.M. Hryshyn, L.A. Gryschuk, I.D. Duzhij, S.M. Ljepshina, L.D. Todoriko, O.S. Shalmin, O.S. Shevchenko, B.M. Puchlykh, Pierpaolo de Colombani, Richard Zaleskis, Vaira Laimane, Girts Shkenders, Alberto Mattelli, Giovanni Battista Migliori

Характеристики книги Phthisiology: textbook / V.I. Petrenko, O.K. Asmolov, M.G. Boyko et al.; edited by V.I. Petrenko. — 2nd edition

Видавництво: Всеукраїнське спеціалізоване видавництво «Медицина»
Форма: друкована книга (видання)
Вид: підручник
Мова: англійська
Рік і номер видання: 2018, 2-е (стереотипне)
Кількість сторінок: 416 (повнокольорове видання)
Обкладинка: тверда
Формат: 70х100/16
Вага: 911 г
ISBN: 978-617-505-687-5 (9786175056875)

Додати відгук

Введіть символи: *

На цій сторінці Ви можете ознайомитися і купити підручник авторів В.І. Петренко, Л.Д. Тодоріко, О.С. Шевченко та ін. Фтизіатрія українською мовою, а також безкоштовно прочитати онлайн фрагмент книги і скачати інформацію про неї. ВСВ «Медицина»